Literature DB >> 22782130

[Stress lesions in the upper gastrointestinal tract].

U Jaschinski1.   

Abstract

Clinically relevant bleeding in the upper gastrointestinal tract due to stress lesions is a rare event; however, the related mortality may be as high as 13% (van Leerdam, Best Pract Res Clin Gastroenterol 2008; 22:209-224). Most often affected are patients in the intensive care unit (ICU) with impaired perfusion as the protective pathways are critically dependent on a near normal blood flow. Minimal mucosal lesions with a tiny hemorrhage can escalate to severe bleeding as the coagulation potential in the presence of an acidic pH is clearly decreased. Mechanical ventilation and coagulopathy are recognized risk factors and these patients should receive an acid suppressing therapy. Proton pump inhibitors (PPI) and histamine type 2 receptor antagonists (H(2)RA) are equal in their ability to prevent stress-related bleeding. However, the side effects of PPI can cause severe morbidity and therefore H(2)RAs may be the drug of choice for prophylaxis. Endoscopy is recommended as a diagnostic and therapeutic tool for patients with active bleeding. Treatment with PPI in this scenario (before and after endoscopy) may reduce complications by leading to premature hemostasis and reduced recurrence of bleeding.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22782130     DOI: 10.1007/s00101-012-2048-7

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  29 in total

1.  Proton pump inhibitors and risk for recurrent Clostridium difficile infection.

Authors:  Amy Linsky; Kalpana Gupta; Elizabeth V Lawler; Jennifer R Fonda; John A Hermos
Journal:  Arch Intern Med       Date:  2010-05-10

2.  Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection.

Authors:  Michael D Howell; Victor Novack; Philip Grgurich; Diane Soulliard; Lena Novack; Michael Pencina; Daniel Talmor
Journal:  Arch Intern Med       Date:  2010-05-10

3.  Randomized, double-blind comparison of immediate-release omeprazole oral suspension versus intravenous cimetidine for the prevention of upper gastrointestinal bleeding in critically ill patients.

Authors:  Steven A Conrad; Andrea Gabrielli; Benjamin Margolis; Andrew Quartin; J Steven Hata; William O Frank; Robert G Bagin; James A Rock; Bonnie Hepburn; Loren Laine
Journal:  Crit Care Med       Date:  2005-04       Impact factor: 7.598

Review 4.  [Newly recognized side-effects of proton pump inhibitors. Arguments in favour of fundoplication for GERD?].

Authors:  B H A von Rahden; M Scheurlen; J Filser; H J Stein; C-T Germer
Journal:  Chirurg       Date:  2012-01       Impact factor: 0.955

Review 5.  Epidemiology of acute upper gastrointestinal bleeding.

Authors:  M E van Leerdam
Journal:  Best Pract Res Clin Gastroenterol       Date:  2008       Impact factor: 3.043

6.  Causes of mortality in patients with peptic ulcer bleeding: a prospective cohort study of 10,428 cases.

Authors:  Joseph J Y Sung; Kelvin K F Tsoi; Terry K W Ma; Man-Yee Yung; James Y W Lau; Philip W Y Chiu
Journal:  Am J Gastroenterol       Date:  2009-09-15       Impact factor: 10.864

7.  Risk factors for ventilator-associated pneumonia: from epidemiology to patient management.

Authors:  Marc J M Bonten; Marin H Kollef; Jesse B Hall
Journal:  Clin Infect Dis       Date:  2004-03-30       Impact factor: 9.079

8.  Nosocomial pneumonia risk and stress ulcer prophylaxis: a comparison of pantoprazole vs ranitidine in cardiothoracic surgery patients.

Authors:  Todd A Miano; Marc G Reichert; Timothy T Houle; Drew A MacGregor; Edward H Kincaid; David L Bowton
Journal:  Chest       Date:  2009-03-24       Impact factor: 9.410

9.  Acid-suppressive medication use and the risk for hospital-acquired pneumonia.

Authors:  Shoshana J Herzig; Michael D Howell; Long H Ngo; Edward R Marcantonio
Journal:  JAMA       Date:  2009-05-27       Impact factor: 56.272

10.  Intravenous non-high-dose pantoprazole is equally effective as high-dose pantoprazole in preventing rebleeding among low risk patients with a bleeding peptic ulcer after initial endoscopic hemostasis.

Authors:  Chih-Ming Liang; Jyong-Hong Lee; Yuan-Hung Kuo; Keng-Liang Wu; Yi-Chun Chiu; Yeh-Pin Chou; Ming-Luen Hu; Wei-Chen Tai; King-Wah Chiu; Tsung-Hui Hu; Seng-Kee Chuah
Journal:  BMC Gastroenterol       Date:  2012-03-28       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.